Login / Signup

Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies.

Susan BalNoel Estrada-MerlyLuciano José Megale CostaMuzaffar H QazilbashShaji K KumarAnita D'Souza
Published in: Blood cancer journal (2023)
Keyphrases
  • stem cell transplantation
  • high dose
  • bone marrow
  • cell therapy
  • platelet rich plasma
  • multiple myeloma
  • low dose
  • adipose tissue
  • metabolic syndrome
  • mesenchymal stem cells
  • weight loss
  • glycemic control
  • insulin resistance